HDAC10 and leukemia: Notably, by binding to the highly conserved active hydrophobic pocket of HDAC10, periplocin could maintain a certain level of drug specificity and high binding affinity, which provide valuable structural insights into the design of HDAC10-specific therapies with potential applications in leukemia treatment.